Last reviewed · How we verify

NCT04502420

Lung Function After Abdominal Surgery

Completed Last updated 25 January 2023
What this trial tests

trial testing Lung function before and after surgery in Lung Function in 59 participants. Completed in 17 October 2021.

Timeline
17 August 2020
Primary endpoint
17 October 2021
17 October 2021

Quick facts

Lead sponsorUmeå University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment59
Start date17 August 2020
Primary completion17 October 2021
Estimated completion17 October 2021
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Umeå University

Who can join

18 and older, any sex, with Lung Function or Postoperative Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to investigate changes in lung function and diffusion capacity for carbon monoxide after open and minimally invasive abdominal surgery and whether such changes can explain hypoxia after surgery. Inclusion: Patients undergoing surgery for abdominal surgery Exclusion: Dementia or cognitive impairment that makes it impossible to participate in studies. Investigation: The day before surgery and the day after surgery Primary outcome measures: * Pulmonary function test with dynamic spirometry (Vital capacity, FEV1) and diffusion capacity for carbon monoxide. * PaO2, PaCO2 and oxygen saturation (blood gas)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lung Function

Currently open trials in the same condition.

Other Umeå University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04502420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing